Editorial Staff

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

/in , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute’s Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Guest:

Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics – both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.

Guest Host:

Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of America.

Get new episodes of Hubwonk in your inbox!

Recent episodes:

Jawboning Free Speech: State Coercion Finds Limits at Supreme Court

Joe Selvaggi talks with Cato Institute legal scholar Thomas Berry about the effects of the 9-0 Supreme Court decision in NRA v. Vullo on states' ability to use regulation to target disfavored free speech.

Protectionism’s Bipartisan Embrace: Who Pays When Imports Cost More

Joe Selvaggi talks with international tax and trade expert Clark Packard about the tension between the economic and political calculus behind the Biden administration's recently announced tariffs on Chinese products, including EVs, batteries, and steel.

Universal Savings Accounts: Designing Tax Incentives that Pay to Save

Joe Selvaggi talks with CATO Institute’s Dr. Adam Michel about the opportunity for tax reforms that promote individual savings, an important foundation for economic growth, personal well-being, and intergenerational support.

Precision Law Enforcement: Can Gunfire Detection Technology Serve and Protect Everyone?

Joe Selvaggi talks with SoundThinking's Senior Vice President Tom Chittum about gunfire location technology promises and pitfalls when deployed by law enforcement in high-crime communities.

Examining Diversity’s Dividends: Can Studies Survive Contact with Peer Review

Joe Selvaggi talks with business data scientist Dr. Jeremiah Green about his peer review work examining consulting firm McKinsey’s studies on the measurable financial benefits of diversity in corporate executive leadership.

Promoting Policy Probity: Confessions of Hubwonk’s Humble Host at 200

Hubwonk's Joe Selvaggi marks episode 200 with a solo podcast that offers some backstory of his journey to becoming a host and offers some insights learned from more than 4 years of interviews.

Losing Local Labor: Retaining Workers Remains a Massachusetts Challenge

Joe Selvaggi talks with Pioneer Institute's Research Associate Aidan Enright about Pioneer's annual report on the Massachusetts labor force and discuss which trends could portend trouble for the state’s future.

Tax Man Confounded: Why High Rates Haven’t Yielded Higher Revenue

Joe Selvaggi talks with economic scholar Dr. Brian Domitrovic about the history of federal tax policy and the reasons for why varied marginal rates fail to correlate with either tax revenue or GDP growth.

Industrial Policy Reimaged: Can Government Improve Free Markets

Joe Selvaggi discusses industrial policy, its aspirations and limitations, with CATO Institute Associate Director Colin Grabow, in response to Senator Rubio's thought piece advocating for a more active role for government in the economy.

Posting Patient Prices: Transparency Cure for Hospital Blank Checks

Joe Selvaggi interviews entrepreneur, philanthropist, and founder of PatientRightsAdvocate.org, Cynthia Fisher, discussing her research and advocacy for enhanced healthcare price transparency. This initiative has the potential to improve life expectancy and save Americans over a trillion dollars annually.